Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer
van der Burg, M.E.L, Onstenk, W, Boere, I.A, Look, M, Ottevanger, P.B, de Gooyer, D, Kerkhofs, L.G.M, Valster, F.A.A, Ruit, J.B, van Reisen, A.G.P.M, Goey, S.H, van der Torren, A.M.E, ten Bokkel Huinink, D, Kok, T.C, Verweij, J, van Doorn, H.C
Published in European journal of cancer (1990) (01.10.2014)
Published in European journal of cancer (1990) (01.10.2014)
Get full text
Journal Article
The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients
Knijn, N, Tol, J, Koopman, M, Werter, M.J.B.P, Imholz, A.L.T, Valster, F.A.A, Mol, L, Vincent, A.D, Teerenstra, S, Punt, C.J.A
Published in European journal of cancer (1990) (01.02.2011)
Published in European journal of cancer (1990) (01.02.2011)
Get full text
Journal Article
Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN
JJ, Michiels, T, Devos, K, Fostier, FA, Valster, V, Potters, K, Schelfout, HD, Raeve
Published in Journal of Hematology and Blood Disorders (01.08.2015)
Published in Journal of Hematology and Blood Disorders (01.08.2015)
Get full text
Journal Article